Envista Holdings Corporation (NVST)
Envista Holdings: A Mixed Picture
Today, we take a deeper look at Envista Holdings Corporation, a dental supply and equipment company. The stock appears to be trying to bottom after a recent decline and despite negative analyst firm opinion on the shares. The company has recently instituted a significant stock buyback program and from a historical perspective, the shares are cheap on a price to sales ratio basis.
Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Continue to Hold NVST Stock in Your Portfolio?
Investors are optimistic about Envista, thanks to its strong momentum in the Specialty Products and Technologies segment.
Why Is Envista (NVST) Down 18.2% Since Last Earnings Report?
Envista (NVST) reported earnings 30 days ago. What's next for the stock?
Reasons to Retain Envista Stock in Your Portfolio for Now
NVST's impressive long-term growth initiatives appear promising. Yet, a leveraged balance sheet is worrisome.
NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes
Envista delivers better-than-expected top and bottom-line results for the fourth quarter of 2024.
Envista Holdings Corporation (NVST) Q4 2024 Earnings Call Transcript
Envista Holdings Corporation (NYSE:NVST ) Q4 2024 Earnings Conference Call February 5, 2025 5:30 PM ET Company Participants Jim Gustafson – Vice President-Investor Relations Paul Keel – President and Chief Executive Officer Eric Hammes – Chief Financial Officer Conference Call Participants Elizabeth Anderson – Evercore ISI Jon Block – Stifel Ahmed Muhammad – Leerink Partners Jeff Johnson – Baird Kevin Caliendo – UBS Erin Wright – Morgan Stanley Steven Valiquette – Mizuho Securities Brandon Vazquez – William Blair Vik Chopra – Wells Fargo Operator Hello. My name is David, and I'll be your conference call facilitator this afternoon.
Here's What Key Metrics Tell Us About Envista (NVST) Q4 Earnings
While the top- and bottom-line numbers for Envista (NVST) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Envista (NVST) Beats Q4 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.29 per share a year ago.
Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Envista Is A Margin Improvement Story (Rating Upgrade)
I upgrade Envista stock to a buy due to its potential for increased profitability in 2025. The Implants segment, NVST's largest business unit, is expected to witness positive sales expansion in the coming quarters by capitalizing on its brand strength in a market with favorable recovery prospects. The clear aligner business targets to achieve positive operating profit for the current year, considering the appointment of new leadership and the company management's recent comments.
Reasons to Retain Envista Stock in Your Portfolio for Now
NVST's strong focus on international market expansion appears promising. Yet, a leveraged balance sheet is worrisome.
